Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above

NCT04100772 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

237

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infections
Streptococcal Infections
Bacterial Infections

Interventions

BIOLOGICAL: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine（CRM197,TT）
BIOLOGICAL: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine

Sponsor

CanSino Biologics Inc.

Collaborators

[object Object]